T1	intervention 32 42	Pregabalin
T2	condition 46 74	Postmastectomy Pain Syndrome
T3	No-of-participants 401 404	200
T4	eligibility 405 477	patients with breast cancer scheduled for elective breast cancer surgery
T5	control 624 637	control group
T6	outcome-Measure 705 736	development of neuropathic PMPS
T7	outcome-Measure 847 853	safety
T8	outcome-Measure 865 886	Analogue Scale scores
T9	outcome 888 904	Neuropathic pain
T10	outcome-Measure 1082 1086	PMPS
T11	intervention-value 1104 1106	11
T12	intervention-value 1117 1120	11%
T13	control-value 1150 1152	29
T14	control-value 1163 1166	29%
T15	outcome 1278 1306	Visual Analogue Scale scores
T16	outcome 1505 1532	frequency of adverse events
